Atherosclerosis in Systemic Lupus Erythematosus : Expanding the Therapeutic Frontier in AtherosclerosisSTOJAN, George; PETRI, Michelle.Journal of cardiovascular pharmacology. 2013, Vol 62, Num 3, pp 255-262, issn 0160-2446, 8 p.Article

IgM Anti-β₂ Glycoprotein I Is Protective Against Lupus Nephritis and Renal Damage in Systemic Lupus ErythematosusMEHRANI, Taraneh; PETRI, Michelle.Journal of rheumatology. 2011, Vol 38, Num 3, pp 450-453, issn 0315-162X, 4 p.Article

Management of thrombosis in antiphospholipid antibody syndromePETRI, Michelle.Rheumatic diseases clinics of North America. 2001, Vol 27, Num 3, issn 0889-857X, VIII, 633-642 [11 p.]Article

Hopkins Lupus Pregnancy Center : 1987 to 1996PETRI, M.Rheumatic diseases clinics of North America. 1997, Vol 23, Num 1, issn 0889-857X, vii, 1-13 [14 p.]Article

Scleroderma and pregnancySTEEN, V. D.Rheumatic diseases clinics of North America. 1997, Vol 23, Num 1, issn 0889-857X, ix, 133-147 [16 p.]Article

Pancreatitis in Systemic Lupus Erythematosus: Frequency and Associated Factors - A Review of the Hopkins Lupus CohortMAKOL, Ashima; PETRI, Michelle.Journal of rheumatology. 2010, Vol 37, Num 2, pp 341-345, issn 0315-162X, 5 p.Article

Prevalence of Flare and Influence of Demographic and Serologic Factors on Flare Risk in Systemic Lupus Erythematosus: A Prospective StudyPETRI, Michelle; SINGH, Sukhminder; TESFASYONE, Hanna et al.Journal of rheumatology. 2009, Vol 36, Num 11, pp 2476-2480, issn 0315-162X, 5 p.Article

Asymmetric dimethylarginine is a marker of poor prognosis and coronary calcium in systemic lupus erythematosusKIANI, Adnan N; MAHONEY, James A; PETRI, Michelle et al.Journal of rheumatology. 2007, Vol 34, Num 7, pp 1502-1505, issn 0315-162X, 4 p.Article

Predictors of carotid atherosclerosis in systemic lupus erythematosusMAKSIMOWICZ-MCKINNON, Kathleen; MAGDER, Laurence S; PETRI, Michelle et al.Journal of rheumatology. 2006, Vol 33, Num 12, pp 2458-2463, issn 0315-162X, 6 p.Article

Tissue factor activity in patients with systemic lupus erythematosus : Association with disease activitySEGAL, Jodi; KICKLER, Thomas; PETRI, Michelle et al.Journal of rheumatology. 2000, Vol 27, Num 12, pp 2827-2832, issn 0315-162XArticle

Placental pathology in systemic lupus erythematosus and phospholipid antibody syndromeSALAFIA, C. M; PARKE, A. L.Rheumatic diseases clinics of North America. 1997, Vol 23, Num 1, pp viii-ix, issn 0889-857X, 15 p.Article

Kidney biopsy in lupus nephritis : look before you leapBIHL, Geoffrey R; PETRI, Michelle; FINE, Derek M et al.Nephrology, dialysis, transplantation (Print). 2006, Vol 21, Num 7, pp 1749-1752, issn 0931-0509, 4 p.Article

High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosusPETRI, Michelle; JONES, Richard J; BRODSKY, Robert A et al.Arthritis and rheumatism. 2003, Vol 48, Num 1, pp 166-173, issn 0004-3591, 8 p.Article

Antiphospholipid antibodies in healthy pregnant womenLYNCH, A; SILVER, R; EMLEN, W et al.Rheumatic diseases clinics of North America. 1997, Vol 23, Num 1, issn 0889-857X, viii, 55-70 [17 p.]Article

Immunosuppressive drug use during pregnancyRAMSEY-GOLDMAN, R; SCHILLING, E.Rheumatic diseases clinics of North America. 1997, Vol 23, Num 1, issn 0889-857X, x, 149-167 [20 p.]Article

Pregnancy and rheumatoid arthritisNELSON, J. L; ØSTENSEN, M.Rheumatic diseases clinics of North America. 1997, Vol 23, Num 1, pp x-xi, issn 0889-857X, 20 p.Article

Flares in lupus : Outcome assessment trial (FLOAT), a comparison between oral methylprednisolone and intramuscular triamcinoloneDANOWSKI, Adriana; MAGDER, Laurence; PETRI, Michelle et al.Journal of rheumatology. 2006, Vol 33, Num 1, pp 57-60, issn 0315-162X, 4 p.Article

The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus CohortPETRI, Michelle.Thrombosis research. 2004, Vol 114, Num 5-6, pp 593-595, issn 0049-3848, 3 p.Conference Paper

Immunosuppressive drug use in pregnancyPETRI, Michelle.Autoimmunity (Print). 2003, Vol 36, Num 1, pp 51-56, issn 0891-6934, 6 p.Article

Epidemiology of systemic lupus erythematosusPETRI, Michelle.Baillière's best practice & research. Clinical rheumatology. 2002, Vol 16, Num 5, pp 847-858, issn 1521-6942, 12 p.Article

Thrombocytopenia in pregnancyBELL, W. R; KICKLER, T. S.Rheumatic diseases clinics of North America. 1997, Vol 23, Num 1, issn 0889-857X, x, 183-194 [13 p.]Article

Low Socioeconomic Status Is Associated with Cardiovascular Risk Factors and Outcomes in Systemic Lupus ErythematosusMAYNARD, Janet W; HONG FANG; PETRI, Michelle et al.Journal of rheumatology. 2012, Vol 39, Num 4, pp 777-783, issn 0315-162X, 7 p.Article

Erythrocyte C4d and Complement Receptor 1 in Systemic Lupus ErythematosusSINGH, Vandana; MAHONEY, James A; PETRI, Michelle et al.Journal of rheumatology. 2008, Vol 35, Num 10, pp 1989-1993, issn 0315-162X, 5 p.Article

Neonatal lupus syndromesTSENG, C.-E; BUYON, J. P.Rheumatic diseases clinics of North America. 1997, Vol 23, Num 1, pp vii-viii, issn 0889-857X, 26 p.Article

Animal models for antiphospholipid syndrome in pregnancyZIPOREN, L; BLANK, M; SHOENFELD, Y et al.Rheumatic diseases clinics of North America. 1997, Vol 23, Num 1, issn 0889-857X, ix, 99-117 [20 p.]Article